SCHEMBL19081547

SCHEMBL19081547

c1cc(-c2ccc3oc4cc5c(cc4c3c2)oc2ccc3ccccc3c25)cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.39
ABCG2 Q9UNQ0 3/20 0.39
PAX8 Q06710 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
PLA2G10 O15496 1/20 0.36
PLA2G2A P14555 1/20 0.36
PLA2G4A P47712 1/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
TDP1 Q9NUW8 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081543 0.96 AHR (0.38) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL10122534 0.96 ABCG2 (0.41) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL19081439 0.93 AHR (0.37) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL10122507 0.92 AHR (0.40) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL19081669 0.92 ABCG2 (0.36) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL17944781 0.91 TDP1 (0.37) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL22063098 0.91 ABCG2 (0.38) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL10122542 0.91 AHR (0.41) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL17945592 0.91 PLA2G2A (0.41) AHRCYP1A2PLA2G10PLA2G2APLA2G4A
SCHEMBL19081510 0.91 ABCG2 (0.44) AHRABCG2PAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PAX8 2336/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885ABCG2 4823/4885PAX8 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.